The safety and efficacy of area under the curve (AUC) monitoring in ICU patients receiving continuous renal replacement therapy (CRRT) has yet to be validated by the literature, but a new study by Wang and colleagues published in Pharmacotherapy on January 30, 2023, seems to shine light on the topic.
Corey Diamond, PharmD
Updates from FDA
Herbs and herbal products have been used during pregnancy for centuries and have recently become popular through the widespread belief that it is “safer to go natural.”
In December 2022, FDA approved Sunlenca (Gilead Sciences, Inc.), the first medication in a new class of drugs used to treat HIV type 1 (HIV-1) in patients who are unable to be successfully treated with other available medications.
Lauren Howell, PharmD
With 77% of Americans taking at least one supplement on a regular basis, it is more important than ever for pharmacists to know about these products.
With a large amount of new, high-quality data available, the Kidney Disease: Improving Global Outcomes (KDIGO) workgroup issued a new comprehensive update on diabetes management in chronic kidney disease (CKD) only 2 short years after the last comprehensive update became available.
Ariel L. Clark, PharmD
At the start of 2023, the American College of Physicians (ACP) released an update to their pharmacological guideline recommendations for the treatment of osteoporosis and low bone mass to prevent fractures in adults.
Clarissa Chan, PharmD
For individuals with suicidal thoughts or who don’t respond to any therapies for depression, ketamine offers a treatment choice, according to Megan Ehret, PharmD, BCPP, from the University of Maryland School of Pharmacy.
What if there were no special steps required of clinicians to help individuals receive medication for opioid use disorder (OUD)? Could this scenario allow patients with OUD to be treated where it’s most convenient for them, even in a pharmacy?